Sophiris Bio (SPHS)

Add to Watchlists
Create an Alert
2.62 +0.02  +0.77% NASDAQ Apr 24, 17:00 Delayed 2m USD
View Full Chart
SPHS Price Chart
View All Events

SPHS Events

Date Type Description
03/27/2017 Earnings Sophiris Bio Inc Fourth Quarter Earnings Results in 2017
11/29/2016 Earnings Sophiris Bio Inc Third Quarter Earnings Results in 2016
08/09/2016 Earnings Sophiris Bio Inc Second Quarter Earnings Results in 2016
View All Performance Charts

SPHS Total Returns Comparison


SPHS One Page Reports



  • URL:
  • Investor Relations URL:
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Next Earnings Release: N/A
  • Last Earnings Release: Mar. 27, 2017
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Sophiris Bio Inc is a clinical-stage biopharmaceutical company. The Company is engaged in research and development of products for the treatment of urological diseases. It is currently developing PRX302 for treatment of benign prostatic hyperplasia.

SPHS Comparables


SPHS Excel Add-In Codes

  • Name: =YCI("SPHS","name")
  • Description: =YCI("SPHS","description")
  • Sector: =YCI("SPHS","sector")
  • Industry: =YCI("SPHS","industry")
  • Est. Current Fiscal Year End: =YCI("SPHS","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 7-Day Trial.

{{}} No credit card required.

Already a subscriber? Sign in.